Roux-en-Y gastric surgery (RYGB) is considered the most effective treatment for obesity and type 2 diabetes, but it is not without risk. Because increased postprandial secretions of certain gut hormones: Glucagon-like peptide 1 (GLP-1), Oxyntomodulin (OXM), and peptide YY (PYY), are one of the possible mechanisms of weight loss, researchers investigated whether subcutaneous infusion of those hormones […]
The type 2 diabetes drug sitagliptin improves survival in patients with diabetes who have been hospitalized with COVID-19, according to Italian researchers. Patients who were given sitagliptin in addition to insulin had a mortality rate of 18 percent, versus 37 percent in similar patients who received insulin alone. Read more
Doctors know that a certain percentage of people with type 1 diabetes will experience what’s called a “partial remission,” after being diagnosed and started on insulin therapy. Partial remission is a period of time in which the patient’s beta–cell function will temporarily be restored. Researchers are seeking to understand what determines which patients will experience this partial […]
New research suggests that regular heat exposure through a hot bath is associated with a beneficial effect on risk factors for type 2 diabetes, including glycated haemoglobin |(HbA1c), which is a measure of blood sugar control. Read more
Diabetic neuropathy, or nerve damage, is a common diabetes complication, with symptoms that can range from numbness and pain in extremities to decreased functioning of internal organs. Vitamin D deficiency has been linked previously to neuropathy, and now researchers say it has a specific link to painful neuropathy. Read more
Research has shown that remission of type 2 diabetes, which can be achieved through intensive weight loss, can restore the insulin production capability of the pancreas. Now new research has found that remission can also restore the pancreas to its pre-diabetes shape and size. Read more
Eating whole grain foods can help prevent type 2 diabetes, researchers say. Even something as simple as having a bowl of whole-grain cereal or a piece of whole-grain toast for breakfast can reduce your long-term risk of developing type 2 diabetes. Read more
A new data modelling study says that the average person with type 1 diabetes in the UK today will live almost eight years less than an average person who does not have diabetes, while those with type 2 diabetes will live almost 2 years less than a person without type 2. Read more
Jardiance (empagliflozin) has been studied for its use in people with heart failure. A study has found it shows effectiveness in patients with reduced ejection fraction (HFrEF). In heart failure with reduced ejection fraction, the heart muscle does not contract efficiently, and a smaller percentage of blood is pumped out of the heart than usual. […]
It’s been recognized for some time that 2 diabetes is associated with an increased risk of dementia. A recent large study provides new insight into both the types of dementia implicated and some of the causative factors, finding that the risk is highest for vascular dementia, and the greatest risk is to individuals with poor […]
Type 1 diabetes can affect young patients in many ways. A recent study found that exposure to glycemic extremes can have a negative impact on healthy brain development and cognitive function, including spatial working memory, in teenagers. Read more
The body’s natural process for cleaning its internal organs is called autophagy, which literally means “self-eating.” Researchers say that diabetes can damage the ability of the kidneys to perform this self-cleaning process, which is one reason the kidneys often become bulky and dysfunctional in people with diabetes. Read more
What can people with diabetes do to prepare to reenter the fitness world once it’s safe to resume pre-pandemic lifestyles? The best way to be ready, says diabetes exercise expert Dr. Sheri Colberg, is to stay as active as possible by doing anything you can right now, at home, outside, or in another safe space. […]
The pharma company Roche is adding a new remote-patient-monitoring tool to its Diabetes Care Platform. Doctors and healthcare team members can enroll patients in the program and personalize the tool according to individual patient needs. The tool will allow healthcare professionals to interact with their patients remotely, a particularly valuable thing in the COVID-19 era. […]
High-protein diets have increased in popularity and are touted by many as effective for weight loss, but there have been conflicting reports on whether there is a difference in health effects between plant-based and animal proteins. A recent study examined whether a primarily plant-based high protein diet could really be the secret to longevity. Read […]
Recent diabetes guidelines have suggested giving type 2 diabetes patients newer glucose-lowering drugs like SGLT2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors, earlier in preference to older drugs like metformin and the sulfonylureas, due to their many benefits. However, for Medicare recipients, the out-of-pocket costs for these drugs are much higher. Read more
Pancreatic beta cells, which are essential to insulin production, are reduced by 40-60% in patients with type 2 diabetes, and 70-97% in patients with type 1 diabetes. Researchers have long sought ways to achieve beta cell regeneration in people with diabetes. Recent research suggests a combination of GLP-1 agonists and DYRK1A inhibitors may work to […]
British researchers say that over the last two decades the number of people with prediabetes who subsequently develop type 2 diabetes has declined. While changes in prediabetes classifications may have contributed, earlier treatment of prediabetes by the National Health Service may also be making a difference. Read more
Drugs from the SGLT2 inhibitor class of diabetes medications have shown benefit in slowing progression of diabetic kidney disease, with a reduced risk of acute kidney injury (AKI) noted in research trials. People at high risk of AKIs who may be considering SGLT2 treatment should discuss the risks and benefits with their doctors. Read more
Some studies have suggested that for people with type 2 diabetes, a form of bariatric surgery called Roux-en-Y gastric bypass has beneficial metabolic effects, independent of weight loss. A new study looks at how the effects on diabetes of weight loss due to diet compare to weight loss from gastric bypass. Read more